Product Images Risedronate Sodium
View Photos of Packaging, Labels & Appearance
- The following chemical structure of Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Risedronate sodium tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. - risedronate sodium 01
- Figure 1 - risedronate sodium 02
- PRINCIPAL DISPLAY PANELNDC 59762-0407-4risedronate sodiumdelayed-release tablets35 mg4 tabletsOnce-a-WeekRx Only - risedronate sodium 03
- risedronate sodium 04
Product Label Images
The following 4 images provide visual information about the product associated with Risedronate Sodium NDC 59762-0407 by Greenstone Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The following chemical structure of Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Risedronate sodium tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. - risedronate sodium 01
![The following chemical structure of Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Risedronate sodium tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. - risedronate sodium 01](https://ndclist.com/assets/spl/images/c89430be-15f1-4b8b-ab7e-738de716ee7d/risedronate-sodium-01.jpg "risedronate-sodium-01.jpg")
Figure 1 - risedronate sodium 02
The figure shows the cumulative incidence of nonvertebral osteoporosis-related fractures over 3 years for patients taking placebo and ACTONEL 5mg. The fractures are categorized by location, including the wrist, humerus, hip, pelvis, leg, and clavicle. The text "9% of Patients" is not related to the figure and may refer to a statistic in the accompanying text that is not included here.*
PRINCIPAL DISPLAY PANELNDC 59762-0407-4risedronate sodiumdelayed-release tablets35 mg4 tabletsOnce-a-WeekRx Only - risedronate sodium 03
risedronate sodium 04
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
